Disease progression in amyotrophic lateral sclerosis: Predictors of survival

Muscle and Nerve

Volumn 25, Issue 5, 2002, Pages 709-714

  Magnus, T ^a   Beck, M ^a   Giess, R ^a   Puls, I ^a   Naumann, M ^a   Toyka, K V ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

ALS FRS; Amyotrophic lateral sclerosis; Motor neuron disease; Progression; Survival

Indexed keywords

ADULT; AGE DISTRIBUTION; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE COURSE; DYSPHAGIA; FORCED EXPIRATORY VOLUME; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MUSCLE ATROPHY; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; RATING SCALE; RETROSPECTIVE STUDY; SEX DIFFERENCE; STATISTICAL ANALYSIS; SURVIVAL;

AGE OF ONSET; AGED; AMYOTROPHIC LATERAL SCLEROSIS; DISEASE PROGRESSION; EXTREMITIES; FEMALE; HUMANS; MALE; MEDULLA OBLONGATA; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0036234975     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.10090     Document Type: Article

References (33)

1. Relationship of manual muscle testing to objective strength measurements
2. Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas, 1985-1988
3. Linear estimates of disease progression predict survival in patients with amyotrophic lateral sclerosis
4. A controlled trial of riluzole in amyotrophic lateral sclerosis
5. Guidelines for the use and performance of quantitative outcome measures in ALS clinical trials
6. Clinical trial in Duchenne dystrophy. I. The design of the protocol
7. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis
8. What are the implications of early diagnosis? Maintaining optimal health as long as possible
9. Amyotrophic lateral sclerosis. Its natural history
10. Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials
11. The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function
12. Muscle strength and functional capacity in 78-81-year-old men and women
13. Amyotrophic lateral sclerosis. A study of its presentation and prognosis
14. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction
15. The epidemiology of amyotrophic lateral sclerosis in Finland. A study based on the death certificates of 421 patients
16. Mortality from amyotrophic lateral sclerosis, other chronic disorders, and electric shocks among utility workers
17. Clinical statistics in 515 fatal cases of motor neuron disease
18. Amyotrophic lateral sclerosis: Mortality risk during the course of the disease and prognostic factors
19. Respiratory function deterioration is not time-linked with upper-limb onset in amyotrophic lateral sclerosis
20. The Riluzole Early Access Programme: Descriptive analysis of 844 patients in France
21. The natural history of ALS in a specified population, with comments on risk factors, prognosis and symptomatic treatments
22. The natural history of amyotrophic lateral sclerosis and the use of natural history controls in therapeutic trials
23. Survival prediction in sporadic amyotrophic lateral sclerosis. Age and clinical form at onset are independent risk factors
24. The natural history of amyotrophic lateral sclerosis
25. Changes in skeletal muscle with aging: Effects of exercise training
26. Studies on epidemiological, clinical, and etiological aspects of ALS disease in Sardinia, Southern Italy
27. Slow toxins, biologic markers, and long-latency neurodegenerative disease in the western Pacific region
28. Prognostic indicators of survival in ALS
29. Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management
30. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis
31. The numbers of limb motor neurons in the human lumbosacral cord throughout life
32. Evaluation of magnesium, calcium and aluminum deposition in bone in situ
33. The size and strength of the quadriceps muscles of old and young men